Balchem Corporation Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated April 22, 2015, reports material corporate governance changes for Balchem Corporation. The filing details the appointment of a new Chief Executive Officer, the entry into a material employment agreement, and amendments to the Company's Bylaws.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and corporate governance.
Material Changes
- Executive Leadership: Theodore L. Harris was appointed President and Chief Executive Officer, effective April 28, 2015. Dino A. Rossi will remain as Executive Chairman of the Board.
- Board Composition: The Board of Directors was amended to increase the number of directors from six to seven. Mr. Harris was appointed as a Class 1 director to fill the vacancy.
- Compensation Structure: A new employment agreement was executed with Mr. Harris, establishing a base salary of $600,000 and significant equity and cash incentives.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary contingencies relate to the terms of the new CEO's employment agreement, specifically regarding severance and change-in-control provisions:
- Severance: In the event of termination without cause, Mr. Harris is entitled to twice his annual base salary paid over 12 months, plus immediate vesting of unvested equity replacement grants.
- Change in Control: If a change in control occurs followed by termination without cause within 24 months, Mr. Harris receives a lump sum equal to twice his base salary plus the prior year's bonus, with immediate vesting of equity.
Key Facts for Investor Verification
- Verify the effective date of Theodore L. Harris's tenure as CEO (April 28, 2015).
- Confirm the total initial compensation package, including the $600,000 base salary, $100,000 sign-on cash bonus, 10,000 stock options, 10,000 restricted shares, and 44,000 equity replacement restricted shares.
- Note the increase in Board size from six to seven directors.
- Review the specific vesting schedules for the restricted shares (ratably over two years) and the conditions for immediate vesting under severance clauses.